• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

Mobile ID World

Mobile ID World

Identification Revolution

  • Mobile ID
    • What Is Mobile ID?
    • Identity Associations
    • Premier Partners
    • FAQ
  • News
  • Solutions
    • Behavioral
    • Facial Recognition
    • Fingerprint Biometrics
    • Iris Biometrics
    • Second Factor
    • Smart Cards
    • Smartphones
    • Vital
    • Voice
    • Wearable Tech
    • Other
  • Applications
    • Access Control
    • Cloud Technology
    • Commerce
    • Enterprise
    • Healthcare
    • Identification
    • Internet of Things
    • Law Enforcement
    • Strong Online Authentication
  • Exclusive
    • Interviews
    • Featured Articles
    • Podcasts
  • Companies
  • Events

Invitae’s Clinical Research App Combines Apple Watch Data with Genetic Testing

November 15, 2019

Invitae's Clinical Research App Combines Apple Watch Data with Genetic Testing

The medical genetics company Invitae has developed a new clinical research platform for the Apple Watch. Dubbed ‘Invitae Discover’, the platform will analyze the biometric information gathered through the Apple Watch in an effort to gain a better understanding of the genetic causes of various diseases.

Invitae has partnered with the American Heart Association’s Scientific Sessions for the first study with the Invitae Discover platform, which will examine the effects of genetics on atrial fibrillation and “other cardiovascular conditions associated with abnormal heart rhythms.” According to Invitae, the Afib CAUSE Study will also bolster their ability to accurately interpret genetic test results.

“The Invitae Discover platform will make it easier to conduct studies that assess genetic test results alongside biometric data, thereby joining basic electrophysiological data with genetic information to advance our understanding of disease and improve clinical care,” said Invitae Chief Medical Officer Robert Nussbaum.

The Afib CAUSE Study is open to patients who have already gone through genetic testing with Invitae, though participants must be based in the U.S. and must be 18 years of age or older. Invitae will then combine the participants’ genetic information with health and activity metrics from Apple HealthKit to determine the impact of genetic variables whose significance is not yet fully understood.

Invitae is a medical company, and consequently must protect the privacy and security of all participants in accordance with HIPAA regulations. The study itself will be carried out under the supervision of an Institutional Review Board.

The Apple Watch first gained ECG capabilities back in 2018, when Apple introduced technology that allowed the Apple Watch Series 4 to detect abnormal heart rhythms and atrial fibrillation. The tech giant has since released the Apple Watch Series 5, which debuted in September and included a slew of new activity and health monitoring features.

Filed Under: Industry News Tagged With: Apple Watch, Biometric, biometric health studies, biometric wearables, biometrics, cardiac biometrics, health studies, Invitae, Invitae Discover, wearables

Related News & Articles

Zwipe Offers Range of Enrollment Options for Biometric Card Customers

Precise Biometrics Finds Its New Chief Financial Officer

IDEMIA Wins Frost & Sullivan’s 2017 Global Company of the Year Award

Primary Sidebar

Register For the Next Virtual Identity Summit

Register now!

Tweets

Sponsored Links

facetec logo

FaceTec’s patented, industry-leading 3D Face Authentication software anchors digital identity, creating a chain of trust from user onboarding to ongoing authentication on all modern smart devices and webcams. FaceTec’s 3D FaceMaps™ make trusted, remote identity verification finally possible. As the only technology backed by a persistent spoof bounty program and NIST/iBeta Certified Liveness Detection, FaceTec is the global standard for Liveness and 3D Face Matching with millions of users on six continents in financial services, border security, transportation, blockchain, e-voting, social networks, online dating and more. www.facetec.com

FACEPHI is a global leader in Facial Recognition technology and in Mobile Biometrics technologies. With a strong concentration in the financial sector, FacePhi’s product is rapidly becoming a service used by banks all over the world. Its implementation doesn’t just save money, it is also a way to attract clients and build loyalty, while increasing the security of transactions for both the customer and the business. To learn more about FacePhi, visit https://www.facephi.com/en/

Recent Posts

  • Another e-Betting Platform Leverages Biometric KYC, Care of Jumio
  • Thai Authorities Approve Mobile ID for Airport Boarding
  • New Yoti Solution Ties Biometrics to e-Signatures
  • Kenya’s New President Pushes for Digital ID By Year’s End
  • MDL, Digital ID Gain Momentum in State Efforts

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives
  • CCPA: Do not sell my personal info.

Follow Us

Copyright © 2023 MobileIDWorld